Diseases, Conditions, Syndromes

Researchers closer to the super bug puzzle

Infectious diseases specialists from Austin Health are working closely with Microbiologists from the University of Melbourne to understand how Staph is becoming resistant to all antibiotic therapies.

Medical research

Can antivirulence drugs stop infections without causing resistance?

Antivirulence drugs disarm pathogens rather than kill them, and although they could be effective in theory, antivirulence drugs have never been tested in humans. A new study to be published in the online journal mBio on Tuesday, ...

Diseases, Conditions, Syndromes

Growing concern over drugs fed to animals

Drugs fed to animals to promote growth and prevent diseases may play a key role in the emergence of antibiotic resistant bacteria, microbiologists said Sunday.

Diseases, Conditions, Syndromes

Aggressive drug therapy aids superbug evolution

New research raises troubling concerns about the use of aggressive drug therapies to treat a wide range of diseases such as MRSA, C. difficile, malaria, and even cancer.

Diseases, Conditions, Syndromes

Copper reduces infection risk by more than 40 percent

Professor Bill Keevil, Head of the Microbiology Group and Director of the Environmental Healthcare Unit at the University of Southampton, has presented research into the mechanism by which copper exerts its antimicrobial ...

page 8 from 10